Minnesota Multidisciplinary Vasculitis Program
The Minnesota Multidisciplinary Vasculitis Program (M2VP) enrolls the 200th adult patient and 1st pediatric patient into the registry!
October 2021

Front Row L to R: S. Thaker, S. Reule, M. Rheault, H. Boyer, C. Fanola, D. Pearson, H. Muster
Back Row L to R: P. Nachman, S. Rajala, L. Ghazi, M. Beard, P. Fazeli, K. Woerner, D. Mueller, M. Pritzker, P. Ardnt
Mission
To provide patients with systemic inflammatory disease or vasculitis with cutting-edge, individualized, comprehensive and integrated multidisciplinary care and access to clinical trials.
Covered Diseases
- Systemic vasculitis:
- Small vessel vasculitis (ANCA-vasculitis, Anti-GBM disease, IgA Vasculitis)
- Medium vessel vasculitis
- Large vessel vasculitis
- Systemic Lupus Erythematosus
Goals
- Provide patients with complex systemic diseases with multidisciplinary care which is organized, streamlined and efficient.
- Provide community physicians and providers with a portal for efficient peer-to-peer consultation or referral.
- Provide patients with access to cutting-edge clinical trials.
- Facilitate translational research.
- Provide a venue for health care providers training in the care of patients with complex systemic diseases.
Multidisciplinary Team
Cardiology
Dermatology
Nephrology
- Patrick Nachman, MD
- Milind Junghare, MD
- Surabhi Thakar, MD
- Katti Woerner, MD
- Michelle Rheault, MD (Pediatrics)
Otolaryngology (ENT)
Pulmonary
Rheumatology
Clinical & Translational Research Team
- Madeline Beard RN, BAN - Nurse Navigator
- Scott Rajala, CCRP - Clinical Research Coordinator
Ongoing Clinical Trials
ANCA Vasculitis
Coming soon!
SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Phase 3 Trial
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis (REGENCY)
Principal Investigator
Surabhi Thakar, MD
Co-Investigators
Patrick Nachman, M
Katti Woerner, MD
Study Coordinator
Joy Bolea, RN, MS
jbolea@umn.edu
Mary McDonald, RN, CCRP
mcdo0664@umn.edu
Phase 2a Trial
A Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis (ITN091AI)
Principal Investigator
Patrick H. Nachman, MD
Study Coordinators
Mary McDonald, RN, CCRP
mcdo0664@umn.edu
Joy Bolea, RN, MS
jbolea@umn.edu